Cargando…
Outcome of Hospitalized Parkinson's Disease Patients with and without COVID‐19
BACKGROUND: The Parkinson's disease (PD) patient population, with an already reduced life expectancy, is rendered particularly vulnerable by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2). OBJECTIVES: We determined the risk factors that increase the risk of death in patients w...
Autores principales: | Parihar, Raminder, Ferastraoaru, Victor, Galanopoulou, Aristea S., Geyer, Howard L., Kaufman, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242623/ https://www.ncbi.nlm.nih.gov/pubmed/34226870 http://dx.doi.org/10.1002/mdc3.13231 |
Ejemplares similares
Ejemplares similares
-
Movement Disorders in COVID-19: Whither Art Thou?
por: Geyer, Howard L., et al.
Publicado: (2020) -
GABA(A) Receptors in Normal Development and Seizures: Friends or Foes?
por: Galanopoulou, Aristea S
Publicado: (2008) -
A transition in the leadership of Epilepsia Open®: A journal update, thank you to the outgoing and introduction of the incoming Editors‐in Chief
por: Galanopoulou, Aristea S.
Publicado: (2018) -
An interview with Nadia Adotevi, 2023 Epilepsia Open Prize winner for basic science
por: Galanopoulou, Aristea S.
Publicado: (2023) -
An interview with Ifrah Zawar, 2023 Epilepsia Open prize winner for clinical research
por: Galanopoulou, Aristea S.
Publicado: (2023)